NO20000324D0 - Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister - Google Patents

Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister

Info

Publication number
NO20000324D0
NO20000324D0 NO20000324A NO20000324A NO20000324D0 NO 20000324 D0 NO20000324 D0 NO 20000324D0 NO 20000324 A NO20000324 A NO 20000324A NO 20000324 A NO20000324 A NO 20000324A NO 20000324 D0 NO20000324 D0 NO 20000324D0
Authority
NO
Norway
Prior art keywords
benzotia
oxa
receptor antagonists
endothelin receptor
diazole derivatives
Prior art date
Application number
NO20000324A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000324L (no
Inventor
Dieter Dorsch
Mathias Osswald
Werner Mederski
Claudia Wilm
Maria Christadler
Claus Jochen Schmitges
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20000324D0 publication Critical patent/NO20000324D0/no
Publication of NO20000324L publication Critical patent/NO20000324L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20000324A 1997-07-23 2000-01-21 Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister NO20000324L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19731571A DE19731571A1 (de) 1997-07-23 1997-07-23 Endothelin-Rezeptor-Antagonisten
PCT/EP1998/003957 WO1999005132A1 (fr) 1997-07-23 1998-06-29 Derives de benzothia(oxa)diazol et leur utilisation comme antagonistes des recepteurs de l'endotheline

Publications (2)

Publication Number Publication Date
NO20000324D0 true NO20000324D0 (no) 2000-01-21
NO20000324L NO20000324L (no) 2000-01-21

Family

ID=7836588

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000324A NO20000324L (no) 1997-07-23 2000-01-21 Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister

Country Status (18)

Country Link
US (1) US6197800B1 (fr)
EP (1) EP1000044A1 (fr)
JP (1) JP2001510836A (fr)
KR (1) KR20010022004A (fr)
CN (1) CN1265102A (fr)
AR (1) AR010933A1 (fr)
AU (1) AU733338B2 (fr)
BR (1) BR9811537A (fr)
CA (1) CA2297315A1 (fr)
DE (1) DE19731571A1 (fr)
HU (1) HUP0003335A2 (fr)
ID (1) ID22978A (fr)
NO (1) NO20000324L (fr)
PL (1) PL338070A1 (fr)
SK (1) SK512000A3 (fr)
TW (1) TW461887B (fr)
WO (1) WO1999005132A1 (fr)
ZA (1) ZA986551B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1130027A1 (fr) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Peptides memnoique, procédé de preparation et ses utilisations
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2165567A1 (fr) * 1993-08-19 1995-02-23 Kent Alan Berryman Derives de substitution de 2(5h)-furanone, 2(5h)-thiophenone et de 2(5h)-pyrrolone; methode de preparation et utilisation comme antagonistes de l'endotheline
DE19509950A1 (de) * 1995-03-18 1996-09-19 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19607096A1 (de) * 1996-02-24 1997-08-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
US6197800B1 (en) 2001-03-06
ZA986551B (en) 1999-09-20
CN1265102A (zh) 2000-08-30
PL338070A1 (en) 2000-09-25
NO20000324L (no) 2000-01-21
DE19731571A1 (de) 1999-01-28
SK512000A3 (en) 2000-07-11
EP1000044A1 (fr) 2000-05-17
WO1999005132A1 (fr) 1999-02-04
AU733338B2 (en) 2001-05-10
KR20010022004A (ko) 2001-03-15
CA2297315A1 (fr) 1999-02-04
AR010933A1 (es) 2000-07-12
AU8802298A (en) 1999-02-16
BR9811537A (pt) 2000-08-29
HUP0003335A2 (hu) 2001-07-30
JP2001510836A (ja) 2001-08-07
ID22978A (id) 1999-12-23
TW461887B (en) 2001-11-01

Similar Documents

Publication Publication Date Title
DK0832082T3 (da) N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister
NO20032277L (no) Aminotiazoler og deres anvendelse som adenosinreseptorantagonister
DK1345920T3 (da) Hidtil ukendte sulfamider og anvendelse deraf som endothelinreceptorantagonister
NO20004121D0 (no) Nye forbindelser og deres anvendelse som positive AMPA- reseptormodulatorer
NO994177D0 (no) Atropisomere av 3-aryl-4(3H)-kinazoloner og deres anvendelse som AMPA-reseptor-antagonister
DK1394150T3 (da) 4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister
NO20031952L (no) 3-aroylinderivater og deres anvendelse som CB2 reseptoragonister
DK0950157T3 (da) Omviklelig muffe
NO20030471D0 (no) Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor
NO985225L (no) Indolderivater nyttige som endotelinreseptorantagonister
DK0733626T3 (da) N-(Benzofurazanyl)-arylsulfonamider og analoger deraf, der kan anvendes som endothelin-receptor-antagonister
NO20014098D0 (no) 3-fenylpyridinderivater og anvendelse derav som NK-1 reseptor antagonister
NO991079L (no) Azinyloksy- og fenoksy-diaryl-karboksylsyre-derivater, deres fremstilling og deres anvendelse som blandede ETA/ETB-endotelin-reseptor-antagonister
NO995482L (no) Ergolinderivater og deres anvendelse som somatostatinreseptorantagonister
NO981522L (no) Aminosyrederivater, deres fremstilling og anvendelse som endotelinantagonister
NO996115L (no) Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister
NO994510D0 (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
DK0839146T3 (da) Piperazinderivater og deres anvendelse som 5-HT1A-antagonister
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO20004144D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse som takykinin reseptor antagonister
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
DK1185525T3 (da) 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidinderivater, fremstilling deraf samt anvendelse deraf som endothelinreceptorantagonister
NO972612D0 (no) Pyridazoner som endotelinreseptorantagonister
NO20035486D0 (no) Benzodiazepinderivater og deres anvendelse som AMPA- reseptorstimulatorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application